Clinical Trials Directory

Trials / Completed

CompletedNCT01160627

Prevention of Contrast-induced Nephropathy in Patients With Acute Myocardial Infarction

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
720 (actual)
Sponsor
Odense University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

OBJECTIVE: To evaluate the efficacy of prevention of contrast induced nephropathy in patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention. DESIGN: Prospective study. SETTING: Three-center study Acute kidney injury was defined as a rise in creatinine \>25% from baseline Serum creatinine will be measured at baseline and each day for the following 3 days and at 30 days. Patients will be randomised to: 1. Standard treatment 2. Standard treatment + acetylcystein for 2 days 3. Standard treatment + Sodium bicarbonate 500 ml / followed by 100 ml/h for 5 hours 4. Standard treatment + acetylcystein for 2 days + Sodium bicarbonate 500 ml / followed by 100 ml/h for 5 hours

Conditions

Interventions

TypeNameDescription
OTHERHydrationSaline hydration
DRUGAcetylcysteineAcetylcystein tablets for 2 days
DRUGSodium bicarbonateSodium bicarbonate 500 ml followed by 100 ml/hour for 5 hours
DRUGCombined Acetylcystein and Sodium BicarbonateSodium bicarbonate 500 ml followed by 100 ml/hour for 5 hours combined with acetylcystein tablets for 2 days

Timeline

Start date
2010-04-01
Primary completion
2013-03-01
Completion
2013-03-01
First posted
2010-07-12
Last updated
2013-03-22

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01160627. Inclusion in this directory is not an endorsement.